[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-johnson-johnson-won-uk-approval-for-its-psoriasis-pill-heres-where-the-stock-could-go-by-2030-KO":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":267,"suggestedPosts":343},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},145266,"존슨앤드존슨, 영국에서 건선 치료제 '필' 승인 획득. 2030년까지 주가가 어디까지 갈 수 있을까","2026-10-26T07:05:00","2026-10-26T01:24:23","\u003Cp>Johnson & Johnson는 이틀 연속으로 두 건의 신약 소식을 발표했으며, 주가는 올해 27.5% 상승했습니다. 인수합병으로 인한 희석 효과가 실적 전망에 영향을 미치며 선행 이익 추정치는 하락했습니다. TIKR 모델은 $263.81에 무엇을 살 수 있는지 보여줍니다.\u003C\u002Fp>","\u003Ch3 id=\"h-k-ey-stats-for-johnson-amp-johnson-stock\" class=\"wp-block-heading\">존슨앤드존슨 주식의 \u003Cstrong>핵심 통계\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>현재 가격:\u003C\u002Fstrong> $263.81\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>목표 가격 (중간값):\u003C\u002Fstrong> ~$342\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>시장 목표 가격:\u003C\u002Fstrong> ~$279\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>잠재적 총 수익률:\u003C\u002Fstrong> ~30%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>연간 IRR:\u003C\u002Fstrong> ~6% \u002F 년\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">지금 라이브: TIKR의 새로운 가치 평가 모델을 사용하여 관심 주식의 잠재 상승폭을 확인하세요 (무료)\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\"> &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-what-happened\" class=\"wp-block-heading\">무슨 일이 있었나요?\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>존슨앤드존슨 (\u003C\u002Fstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?ref=k8i24l&amp;cid=139677&amp;?ref=tikrblog\">\u003Cstrong>JNJ\u003C\u002Fstrong>\u003C\u002Fa>\u003Cstrong>)\u003C\u002Fstrong>은 10월 23일 $263.81에 거래를 마쳤으며, 2026년 현재 27.5% 상승했습니다. 또한 이틀 만에 두 건의 신약 관련 소식이 있었습니다. 금요일 영국에서 경구용 건선 치료제 Icotyde의 승인을 받았고, 토요일 주간 시장이 마감된 후 ESMO 회의에서 새로운 ERLEADA 전립선암 데이터가 발표되었습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">전망 이익 추정치는 6월 이후 J&amp;J가 인수 비용을 흡수하면서 하락했지만, 주가는 \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio\">전망 이익의 약 24배\u003C\u002Fa>에 거래되고 있으며, 이는 2025년 9월의 약 16배에서 상승한 수준입니다. 이 새로운 데이터는 최고재무책임자(CFO) 조 월크가 주당 $1.36의 희석 효과를 포함한다고 말한 2027년에 이 배수를 지탱해야 합니다.\u003C\u002Fp>\n\n\n\n\u003Ch3 id=\"h-erleada-data-and-an-icotyde-approval-back-a-growth-plan-built-without-deals\" class=\"wp-block-heading\">\u003Cstrong>ERLEADA 데이터와 Icotyde 승인, 인수합병 없이 구축된 성장 계획을 뒷받침\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">10월 24일 마드리드에서 열린 ESMO 회의에서 J&amp;J는 ERLEADA와 호르몬 요법을 수술 전후 6개월 동안 병용 투여했을 때, 고위험 전립선암에서 \u003Ca href=\"https:\u002F\u002Fwww.jnj.com\u002Fmedia-center\u002Fpress-releases\u002Fjohnson-johnson-announces-erleada-apalutamide-treatment-before-and-after-surgery-reduces-risk-of-recurrence-or-death-by-62-versus-surgery-alone-in-high-risk-prostate-cancer\">수술 단독 대비 재발 또는 사망 위험을 62% 감소시켰다고\u003C\u002Fa> 보고했습니다. 이 개방형 하위 연구는 408명의 환자를 무작위 배정했으며, 이 요법은 이 용도로 승인되지 않았습니다. 5월에 발표된 주요 PROTEUS 시험은 호르몬 요법 단독 대비 전이 또는 사망 위험이 20% 낮다는 것을 보여주었습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">그 전날, 영국의 의약품 규제 기관은 올해 미국에서 출시한 J&amp;J의 1일 1회 경구약 \u003Ca href=\"https:\u002F\u002Fwww.yahoo.com\u002Fnews\u002Fscience\u002Farticles\u002Fuk-approves-j-js-oral-121013563.html\">Icotyde를 승인했습니다\u003C\u002Fa>. 해당일 주가는 1.42% 하락한 채 마감했는데, 이 날은 Merck (MRK)와 Eli Lilly (LLY)도 하락했고, \u003Ca href=\"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fjohnson-and-johnson-stock-smith-nephew-merger-talks-collapse\">J&amp;J의 정형외과 부문과 Smith &amp; Nephew 간의 협상이 결렬되었다는 보도가\u003C\u002Fa> 나온 세션이었습니다. 10월 13일 컨퍼런스콜에서 회장 겸 최고경영자(CEO) 호아킨 두아토는 9,000명 가까운 처방의를 통해 20,000명 이상의 미국 환자가 Icotyde 치료를 시작했다고 말했지만, J&amp;J는 그 매출을 공개하지 않았습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">혁신 의약품 부문 전무이사 겸 전세계 회장인 톰 카바노는 방광암 치료제 INLEXZO가 3분기에 $9천만 달러 이상의 매출을 기록했으며, 신규 환자 유입이 2분기 대비 45% 증가했다고 밝혔습니다. 그는 현재 치료 인구를 약 4,000명으로 추정했으며, 약 15,000명과 50,000명에 달하는 더 넓은 연구 인구를 언급했습니다. 월크는 10년대 말까지 두 자릿수 성장이라는 목표가 내부 투자에 기반한다고 말했습니다: \"현 시점에서는 어떤 외부적 추가(인수합병)도 가정하지 않습니다.\"\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3023\" height=\"2015\" data-public-id=\"images\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3023,h_2015,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA\" alt=\"\" class=\"wp-post-145266 wp-image-145278\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792973382\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 3023w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792973382\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1\u002FTIKR.com_Johnson-Johnson-JNJ-Drawdowns-1.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3023px) 100vw, 3023px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">존슨앤드존슨 최대 낙폭 \u003Cstrong>(\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fmarkets?fid=1&amp;?ref=tikrblog\">TIKR\u003C\u002Fa>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>TIKR는 존슨앤드존슨에 대해 23명의 애널리스트를 추적합니다. '매수' 의견은 몇 명일까요?\u003Cbr>\u003C\u002Fstrong> 존슨앤드존슨의 매수, 보유, 매도 등급과 월스트리트의 매출 및 이익 추정치를 한곳에서 확인하세요. 500,000명 이상의 투자자가 TIKR을 사용하여 이와 같은 주식을 분석합니다. \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?ref=k8i24l&amp;cid=139677&amp;?ref=tikrblog\">존슨앤드존슨 애널리스트 등급 보기\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-deal-dilution-cut-forward-eps-as-the-multiple-rose\" class=\"wp-block-heading\">\u003Cstrong>\u003Cstrong>인수합병 희석 효과로 전망 EPS가 하락하는 동안 배수는 상승\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR의 향후 12개월 정상화 EPS 추정치는 6월 28일 약 $11.80에서 10월 23일 약 $11.10으로 하락한 반면, 주가는 $254.66에서 $263.81로 상승했습니다. 이 하락은 6월 8일에 발표된 Firefly Bio 인수와 Sail Biomedicines 협업에 대해 J&amp;J가 7월에 제시한 가이던스에 포함된 희석 효과와 일치합니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">월크는 이 두 건의 거래가 2026년 조정 EPS에서 $0.64, 2027년 조정 EPS에서 $1.36을 차감한다고 말했습니다. 이를 제외하면, 2026년 조정 EPS 성장률은 중간값 가이던스의 2.9%에 비해 9%에 가까울 것이라고 덧붙였습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">약 24배에 거래되는 J&amp;J의 NTM P\u002FE는 약 17배인 Merck와 Novartis (NOVN)보다 높지만, TIKR 경쟁사 화면에서 약 33배인 Eli Lilly보다는 낮습니다. 이 프리미엄은 의약품 부문에 기반하고 있으며, 혁신 의약품 부문은 3분기에 운영 기준 7.9% 성장했고 메드테크 부문은 2.5% 성장했습니다. $55억 달러 규모의 난소 탈크 합의는 아직 남은 청구의 최소 95% 이상의 참여가 필요하며, 월크는 J&amp;J가 이 기준을 충족하는 추세에 있다고 말했습니다.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"3023\" height=\"2015\" data-public-id=\"images\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_3023,h_2015,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA\" alt=\"\" class=\"wp-post-145266 wp-image-145279\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792973407\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 3023w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_767,h_511,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 767w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1024,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 600w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1365,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_933,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_799,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1792973407\u002Fimages\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a\u002FTIKR.com_Johnson-Johnson-JNJ-NTM-Price-_-Normalized-Earnings-P_E-1_14527969e8a.webp?_i=AA 299w\" sizes=\"auto, (max-width: 3023px) 100vw, 3023px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">존슨앤드존슨 NTM 주가 \u002F 정상화 이익 \u003Cstrong>(\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fmarkets?fid=1&amp;?ref=tikrblog\">TIKR\u003C\u002Fa>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 id=\"h-tikr-advanced-model-analysis\" class=\"wp-block-heading\">\u003Cstrong>TIKR 고급 모델 분석\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>현재 가격:\u003C\u002Fstrong> $263.81\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>목표 가격 (중간값):\u003C\u002Fstrong> ~$342\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>잠재적 총 수익률:\u003C\u002Fstrong> ~30%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>연간 IRR:\u003C\u002Fstrong> ~6% \u002F 년\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"4968\" height=\"4084\" data-public-id=\"images\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_4968,h_4084,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA\" alt=\"\" class=\"wp-post-145266 wp-image-145280\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1792973417\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 4968w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_631,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1263,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1684,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1199,h_986,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 1199w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1399,h_1150,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 1399w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_299,h_246,c_scale\u002Ff_webp,q_auto\u002Fv1792973417\u002Fimages\u002FJNJ_valuation_model-1_145280708c9\u002FJNJ_valuation_model-1_145280708c9.webp?_i=AA 299w\" sizes=\"auto, (max-width: 4968px) 100vw, 4968px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">존슨앤드존슨 고급 가치 평가 모델 \u003Cstrong>(\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fmarkets?fid=1&amp;?ref=tikrblog\">TIKR\u003C\u002Fa>)\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR 모델의 중간 시나리오는 2030년 12월 31일까지 약 $342를 예상하며, 이는 $263.81보다 약 30% 높거나 연간 약 6%에 해당합니다. 2030년 매출에 대한 애널리스트 합의(10명으로 적음)는 2025년부터 2030년까지 매출이 연간 약 7% 성장하고 2030년 정상화 순이익률이 약 31%에 달할 것으로 보고 있습니다. 두아토는 DARZALEX, TREMFYA, Icotyde, RYBREVANT 및 INLEXZO를 J&amp;J의 의약품 성장 동력으로 꼽았습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">INLEXZO와 Icotyde의 더 빠른 적응증 확대가 상승 요인이며, Merck의 17배 수준으로 하락하는 배수가 하락 요인입니다. 시장의 평균 목표가는 약 $279이며, 매수 11건, 우등주 5건, 보유 6건, 매도 1건의 등급이 있습니다. 연간 약 6%의 중간 시나리오는 저평가된 주식이라기보다는 적정 가치를 반영한 주식을 설명하며, 이는 새로운 증거에 의존하는 대규모 매수 케이스를 남겨둡니다.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-conclusion\" class=\"wp-block-heading\">\u003Cstrong>결론\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">두 가지 결과 발표가 먼저 예상됩니다: J&amp;J는 올해 말 INLEXZO 방광암 데이터와 Icotyde 건선성 관절염 데이터를 기대하고 있습니다. 더 큰 시험은 12월 8일로, J&amp;J가 약 $11.60의 정상화 2027년 EPS에 대한 TIKR 합의와 비교하여 2027년 전망에 대한 더 자세한 내용을 제시할 때입니다. 그 안에 $1.36의 희석 효과가 포함된 상태에서 이 수준 이상의 가이던스는 약 24배의 배수를 뒷받침할 것이며, 크게 미달하는 수치는 그 배수를 방어하기 어렵게 만들 것입니다.\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-so-what-is-johnson-amp-johnson-stock-actually-worth\" class=\"wp-block-heading\">\u003Cstrong>그렇다면 존슨앤드존슨 주식의 실제 가치는 얼마일까요?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">TIKR를 사용하면 1분 안에 모든 주식의 미래 가격을 예측할 수 있습니다. TIKR의 가치 평가 모델에 몇 가지 가정을 입력하기만 하면 \u003Cstrong>존슨앤드존슨\u003C\u002Fstrong>의 잠재적 가치를 확인할 수 있습니다. 월스트리트 합의 추정치에서 시작하거나, 비즈니스에 대한 자신의 견해를 반영하도록 입력값을 조정하세요. 무료로 사용할 수 있습니다.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>TIKR 무료로 존슨앤드존슨 분석하기 →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 id=\"h-disclaimer\" class=\"wp-block-heading\">\u003Cstrong>면책 조항:\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>TIKR의 기사는 TIKR 또는 저희 콘텐츠 팀의 투자 또는 재무 조언으로 의도된 것이 아니며, 특정 주식을 사거나 팔도록 권장하는 내용도 아님을 유의하시기 바랍니다. 저희는 TIKR 터미널의 투자 데이터와 애널리스트 추정치를 바탕으로 콘텐츠를 작성합니다. 저희 분석에는 최근 기업 뉴스나 중요한 업데이트가 포함되지 않을 수 있습니다. TIKR은 언급된 모든 주식에 대해 포지션을 보유하고 있지 않습니다. 읽어주셔서 감사합니다, 행복한 투자 되세요!\u003C\u002Fem>\u003C\u002Fp>",1018,"ko","\u002Fblog\u002Fjohnson-johnson-won-uk-approval-for-its-psoriasis-pill-heres-where-the-stock-could-go-by-2030","johnson-johnson-won-uk-approval-for-its-psoriasis-pill-heres-where-the-stock-could-go-by-2030","images\u002F3-20_145269da577\u002F3-20_145269da577","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792973012\u002Fimages\u002F3-20_145269da577\u002F3-20_145269da577.png?_i=AA",{"altText":237,"imageCredit":238},"Johnson &amp; Johnson Won UK Approval for Its Psoriasis Pill. Here’s Where the Stock Could Go by 2030","@Elisanth_ from Getty Images via Canva, @Elements Interactive from Pexels via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Wiltone Asuncion","wiltonetikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"David Hanson","davidtikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"주식 리뷰","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Johnson &#038; Johnson added two pieces of drug news in two days, and the stock is up 27.5% this year. Forward earnings estimates fell as deal dilution hit guidance. The TIKR model shows what $263.81 buys.",{"title":260,"description":261,"twitterTitle":260,"twitterDescription":261,"author":240,"articlePublisher":262,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":263,"twitterData1":264,"ogTitle":260,"ogDescription":261,"ogUrl":232,"ogImage":235,"ogImageWidth":265,"ogImageHeight":266,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"Johnson & Johnson Won UK Approval for Its Psoriasis Pill. Here’s Where the Stock Could Go by 2030","Johnson & Johnson added two pieces of drug news in two days, and the stock is up 27.5% this year. Forward earnings estimates fell as deal dilution hit guidance. The TIKR model shows what $263.81 buys.","TIKR.com","예상 독서 시간","5 minutes",1200,630,[268,283,298,313,328],{"id":255,"title":269,"date":270,"excerpt":271,"wordCount":272,"uri":273,"slug":274,"cloudinaryAssetId":275,"featuredImageOriginalUrl":276,"featuredImageMetadata":277,"author":278,"categories":280,"relatedPosts":282},"Nvidia 주가, 10월에 AI 지출 의심에 기술주 타격으로 거의 8% 하락. 2031년까지 주가가 갈 수 있는 곳은 다음과 같습니다","2026-10-26 07:00:00","Nvidia의 유일한 매도 의견은 고객 자금 조달이 숨겨진 할인처럼 작용하며, 순현금이 1월 이후 절반 이상 감소했다고 지적합니다. Nvidia 자체 서류는 보증이 어디로 가는지 보여줍니다.",922,"\u002Fblog\u002Fnvidia-stock-fell-nearly-8-in-october-as-ai-spending-doubts-hit-tech-stocks-heres-where-the-stock-could-go-by-2031","nvidia-stock-fell-nearly-8-in-october-as-ai-spending-doubts-hit-tech-stocks-heres-where-the-stock-could-go-by-2031","images\u002F2-19_145268f960c\u002F2-19_145268f960c","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792972994\u002Fimages\u002F2-19_145268f960c\u002F2-19_145268f960c.png?_i=AA",{"altText":269},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":279},[],[281],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":284,"date":285,"excerpt":286,"wordCount":287,"uri":288,"slug":289,"cloudinaryAssetId":290,"featuredImageOriginalUrl":291,"featuredImageMetadata":292,"author":293,"categories":295,"relatedPosts":297},"Meta 주가가 실적 상회에도 하루 만에 7% 하락했습니다. 매도할 시기인가, 아니면 매수할 시기인가?","2026-10-24 20:50:00","Meta는 매출에서 기대를 뛰어넘었음에도 AI 지출 우려로 테크주가 타격을 받으며 하루 만에 7% 하락했습니다. 이어닝스 콜에서 Muse의 비용이 어떻게 감소하는지에 대한 수치가 제시되었습니다.",995,"\u002Fblog\u002Fmeta-stock-fell-7-in-a-day-after-a-revenue-beat-time-to-sell-or-load-up","meta-stock-fell-7-in-a-day-after-a-revenue-beat-time-to-sell-or-load-up","images\u002F13-9_1449699b2ed\u002F13-9_1449699b2ed","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852857\u002Fimages\u002F13-9_1449699b2ed\u002F13-9_1449699b2ed.png?_i=AA",{"altText":284},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":294},[],[296],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":299,"date":300,"excerpt":301,"wordCount":302,"uri":303,"slug":304,"cloudinaryAssetId":305,"featuredImageOriginalUrl":306,"featuredImageMetadata":307,"author":308,"categories":310,"relatedPosts":312},"넷플릭스가 2026년 현재 거의 30% 하락했습니다. 매도할 시점일까요, 아니면 대량 매수할 시점일까요?","2026-10-24 20:45:00","넷플릭스의 공동 CEO는 2026년에 미국 쇼가 더블과 트리플을 기록할 때, 나머지 세계는 홈런이 필요하다고 말합니다. 주가가 $65.85에 달하고 디즈니보다 스포티파이에 가까운 가격으로 책정된 상황에서, TIKR 모델은 구매자가 무엇에 대해 돈을 지불하는지 보여줍니다.",1008,"\u002Fblog\u002Fnetflix-is-down-nearly-30-in-2026-time-to-sell-or-load-up","netflix-is-down-nearly-30-in-2026-time-to-sell-or-load-up","images\u002F12-9_144968b5caa\u002F12-9_144968b5caa","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852841\u002Fimages\u002F12-9_144968b5caa\u002F12-9_144968b5caa.png?_i=AA",{"altText":299},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":309},[],[311],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":314,"date":315,"excerpt":316,"wordCount":317,"uri":318,"slug":319,"cloudinaryAssetId":320,"featuredImageOriginalUrl":321,"featuredImageMetadata":322,"author":323,"categories":325,"relatedPosts":327},"코카콜라 주가 52주 최고가 달성 다음날 하락, 10월 27일 인도가 중요한 이유","2026-10-24 20:40:00","코카콜라가 10월 23일 시장 전체의 매도세 속에서 52주 고점을 기록한 다음 날 2.76% 하락했습니다. 최근 실적 보고서에 따르면 아시아 태평양 지역이 가장 많은 판매량을 추가했지만 인도에서는 점유율을 잃었으며, 10월 27일 발표되는 실적에서 주목해야 할 부분이 바로 이 라인입니다.",879,"\u002Fblog\u002Fcoca-cola-stock-fell-a-day-after-a-52-week-high-heres-why-india-matters-on-october-27","coca-cola-stock-fell-a-day-after-a-52-week-high-heres-why-india-matters-on-october-27","images\u002F11-10_14496728c3f\u002F11-10_14496728c3f","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852801\u002Fimages\u002F11-10_14496728c3f\u002F11-10_14496728c3f.png?_i=AA",{"altText":314},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":324},[],[326],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":329,"date":330,"excerpt":331,"wordCount":332,"uri":333,"slug":334,"cloudinaryAssetId":335,"featuredImageOriginalUrl":336,"featuredImageMetadata":337,"author":338,"categories":340,"relatedPosts":342},"ServiceNow, 보안 분야 1위를 꿈꾼다. 77억 5천만 달러의 Armis 인수 성과는 10월 28일에 드러난다","2026-10-24 20:35:00","ServiceNow CEO는 회사가 기업 보안 벤더 중 8위를 차지하고 있으며 1위를 목표로 하고 있다고 밝혔습니다. 이 목표를 뒷받침하는 인수합병은 이미 GAAP 마진에 부담을 주고 있으며, 그가 이 발언을 한 후 첫 실적 발표일이 10월 28일입니다.",965,"\u002Fblog\u002Fservicenow-wants-to-be-no-1-in-security-heres-what-its-7-75-billion-armis-bet-must-show-on-october-28","servicenow-wants-to-be-no-1-in-security-heres-what-its-7-75-billion-armis-bet-must-show-on-october-28","images\u002F10-13_1449664c7d7\u002F10-13_1449664c7d7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792852762\u002Fimages\u002F10-13_1449664c7d7\u002F10-13_1449664c7d7.png?_i=AA",{"altText":329},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":339},[],[341],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[344,363,377,394,411],{"id":255,"title":345,"date":270,"excerpt":346,"wordCount":347,"uri":348,"slug":349,"cloudinaryAssetId":350,"featuredImageOriginalUrl":351,"featuredImageMetadata":352,"author":353,"categories":357,"relatedPosts":362},"SK하이닉스, 10월 28일 주주환원 약속: 120억 달러 특별배당금 지급 가능할까?","SK하이닉스는 추정 자유현금흐름의 약 70%를 되돌려줄 수 있습니다. 수요일에 발표될 배당금 규모가 주주와 솔리딤 중 누가 현금을 받을지 보여줄 것입니다.",820,"\u002Fblog\u002Fsk-hynix-promises-shareholder-returns-on-october-28-can-it-pay-a-12-billion-special-dividend","sk-hynix-promises-shareholder-returns-on-october-28-can-it-pay-a-12-billion-special-dividend","images\u002FFEATURED-IMAGE-MAKER-1896\u002FFEATURED-IMAGE-MAKER-1896","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792994007\u002Fimages\u002FFEATURED-IMAGE-MAKER-1896\u002FFEATURED-IMAGE-MAKER-1896.png?_i=AA",{"altText":345},{"name":354,"slug":355,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":356},"Gian Estrada","giantikr",[],[358],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},"일반 투자","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":364,"date":270,"excerpt":365,"wordCount":366,"uri":367,"slug":368,"cloudinaryAssetId":369,"featuredImageOriginalUrl":370,"featuredImageMetadata":371,"author":372,"categories":374,"relatedPosts":376},"머스크, \"스페이스X, 엔비디아 승리로 칩 공급에 400억 달러 확보\" 발언: \"우리는 투자 등급이다\"","머스크는 스페이스X가 GPU를 위해 400억 달러의 부채를 마감했다고 밝혔습니다. 엔비디아의 경우 이 자금은 2027년 수요를 뒷받침하지만, 헤드라인이 암시하는 것보다 훨씬 작은 규모의 거래입니다.",883,"\u002Fblog\u002Fmusk-says-spacex-locked-in-40-billion-for-chips-a-win-for-nvidia-were-investment-grade","musk-says-spacex-locked-in-40-billion-for-chips-a-win-for-nvidia-were-investment-grade","images\u002FFEATURED-IMAGE-MAKER-1897\u002FFEATURED-IMAGE-MAKER-1897","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792996223\u002Fimages\u002FFEATURED-IMAGE-MAKER-1897\u002FFEATURED-IMAGE-MAKER-1897.png?_i=AA",{"altText":364},{"name":354,"slug":355,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":373},[],[375],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[],{"id":255,"title":378,"date":379,"excerpt":380,"wordCount":381,"uri":382,"slug":383,"cloudinaryAssetId":384,"featuredImageOriginalUrl":385,"featuredImageMetadata":386,"author":387,"categories":391,"relatedPosts":393},"Bloom Energy, 6월 최고치 대비 44% 하락… 실적 발표 후 주가를 끌어내린 바로 그 수치","2026-10-26 00:59:42","캐시를 보여줘, 블룸.",685,"\u002Fblog\u002Fbloom-energy-is-44-below-its-june-record-heres-the-number-that-sank-it-after-earnings","bloom-energy-is-44-below-its-june-record-heres-the-number-that-sank-it-after-earnings","images\u002F4-10_125274308d0\u002F4-10_125274308d0","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1787164294\u002Fimages\u002F4-10_125274308d0\u002F4-10_125274308d0.png?_i=AA",{"altText":378},{"name":388,"slug":389,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":390},"Rexielyn Diaz","rexietikr",[],[392],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[],{"id":255,"title":395,"date":396,"excerpt":397,"wordCount":398,"uri":399,"slug":400,"cloudinaryAssetId":401,"featuredImageOriginalUrl":402,"featuredImageMetadata":403,"author":404,"categories":408,"relatedPosts":410},"Bank Of America, ServiceNow 주가 목표치 상향 조정... Q3 실적 발표 앞두고","2026-10-26 00:38:00","Bank of America는 ServiceNow의 목표 주가를 180달러로 상향 조정하고 10월 28일 발표 예정인 3분기 실적 발표를 앞두고 매수 등급을 유지했습니다. 주목해야 할 점은 다음과 같습니다.",616,"\u002Fblog\u002Fbank-of-america-raises-servicenow-price-target-third-quarter-earnings","bank-of-america-raises-servicenow-price-target-third-quarter-earnings","images\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792819580\u002Fimages\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva\u002FNOW-stock-@Melpomenem-from-Getty-Images-via-Canva-@Monster-Ztudio-via-Canva.png?_i=AA",{"altText":395},{"name":405,"slug":406,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":407},"Aditya Raghunath","adityatikr",[],[409],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[],{"id":255,"title":412,"date":413,"excerpt":414,"wordCount":415,"uri":416,"slug":417,"cloudinaryAssetId":418,"featuredImageOriginalUrl":419,"featuredImageMetadata":420,"author":421,"categories":425,"relatedPosts":427},"UnitedHealth, RBC의 $498 목표가에 3.5% 상승하며 관리 의료주 상승","2026-10-25 18:44:00","실적 발표 후 일주일이 지났지만, 애널리스트들은 여전히 배수에 대해 논쟁 중입니다.",721,"\u002Fblog\u002Funitedhealth-gains-3-5-on-rbcs-498-price-target-as-managed-care-stocks-rally","unitedhealth-gains-3-5-on-rbcs-498-price-target-as-managed-care-stocks-rally","images\u002FUnitedHealth-Stock\u002FUnitedHealth-Stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1792780120\u002Fimages\u002FUnitedHealth-Stock\u002FUnitedHealth-Stock.png?_i=AA",{"altText":412},{"name":422,"slug":423,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":424},"Bobby Sankhagowit","bobby",[],[426],{"name":359,"slug":360,"uri":361,"description":243,"postsCount":255},[]]